Northwestern Mutual Wealth Management
CASC

Northwestern Mutual Wealth Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-33
Closed – – 2613
2016
Q3 		$0 Buy
+33
New +$234 ﹤0.01% 2414
2015
Q2 		– Sell
-56
Closed -$1K – 1737
2015
Q1 		$1K Buy
+56
New +$549 ﹤0.01% 1516

Other funds holding CASC

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SH
Sandia Holdings Greenwich, Connecticut $213M AUM 29.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Northwestern Mutual Wealth Management's CASC Position: Q4 2016 in Review

Northwestern Mutual Wealth Management sold out of Cascadian Therapeutics, Inc. (CASC) in Q4 2016, closing a stake of 33 shares.

Northwestern Mutual Wealth Management first reported a position in CASC in Q1 2015 and held it in 2 quarters. The position peaked at $1K in Q1 2015. 57 funds tracked by Wall St. Rank hold CASC as of Q4 2016.

  • Northwestern Mutual Wealth Management reported no remaining Cascadian Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 33 Cascadian Therapeutics, Inc. shares in Q4 2016.
  • Northwestern Mutual Wealth Management first reported a position in Cascadian Therapeutics, Inc. in Q1 2015 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Cascadian Therapeutics, Inc. position peaked at $1K in Q1 2015.
  • 57 funds tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q4 2016.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2016, filed 15 Feb 2017.